Neurocrine Biosciences

Preço das Ações
130.51
Mudança Diária
2.13 1.66%
Mensal
-2.97%
Anual
12.61%
Q1 Previsão
124.64




Ebit Alterar Data
AbbVie USD 5.81B 4.36B 2025-12
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
ALKERMES USD 89.08M 3.9M 2025-09
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amgen USD 3.96B 464M 2025-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Cytokinetics USD -166.76M 55.25M 2025-09
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Exelixis USD 235.91M 20.45M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Incyte USD 383.88M 47.44M 2025-12
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Pfizer USD 4.65B 71M 2025-12
Prothena USD -39.76M 12.25M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Repligen USD 16.81M 10.85M 2025-09
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Teva Pharmaceutical Industries USD 577M 491M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Xoma USD -10.08M 4.4M 2024-06


Neurocrine Biosciences - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.